Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
Genes, Chromosomes & Cancer|October 24, 2015
Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenomaNicole Pfarr, Hans-Peter Sinn, Frederick Klauschen, et al.Translational Lung Cancer Research|December 4, 2018
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and cliniciansMichael Allgäuer, Jan Budczies, Petros Christopoulos, et al.Genes, Chromosomes & Cancer|October 30, 2016
Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevanceNicole Pfarr, Roland Penzel, Volker Endris, et al.Nature Genetics|May 18, 2010
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardationSimone Berkel, Christian R Marshall, Birgit Weiss, et al.Genes, Chromosomes & Cancer|September 20, 2018
Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker studyAnna-Lena Volckmar, Volker Endris, Matthias M Gaida, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2022
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept studyJana Friedhoff, Felix Schneider, Christina Jurcic, et al.Oncotarget|August 14, 2014
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasmAlbrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.International Journal of Cancer|September 22, 2018
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysisIvo Buchhalter, Eugen Rempel, Volker Endris, et al.International Journal of Cancer|January 24, 2020
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primaryTilmann Bochtler, Anna Reiling, Volker Endris, et al.Genes, Chromosomes & Cancer|March 27, 2020
Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencingSuranand B Talla, Eugen Rempel, Volker Endris, et al.Pageof 12